Pozen: POZN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pozen: POZN

POZN 5.940

0.0%

Feb 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: IRWIN JAMES FRANKEL	6/26/2006 8:14:34 AM
	Read Replies (2) of 19

08:11 POZN POZEN: Discussions at AHS confirm Trexima safety - Jefferies (6.73 ) Jefferies says their discussions with investigators and GSK, coupled with additional long-term safety data at AHS, show no out-of-ordinary safety issues for Trexima. Furthermore, firm says that more safety information asked by the FDA could be relatively quickly resolved, perhaps without additional trials. Firm would buy POZN on its attractive risk/reward profile.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next